Drupal.behaviors.print = function(context) {window.print();window.close();}>
Danaher Q3 Revenues Dip Slightly, Lowers 2012 EPS Guidance
October 18, 2012
Danaher Q3 Revenues Dip Slightly, Lowers 2012 EPS Guidance
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Danaher's Q1 Revenues up 31 Percent, Aided by Beckman Coulter Purchase
April 19, 2012 / GenomeWeb Daily News
Danaher Q3 Revenues Increase 46 Percent
October 20, 2011 / GenomeWeb Daily News
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
Cancer Genetics Reports 45 Percent Increase in Q1 Revenues, Maps out Growth Strategy
May 16, 2013 / GenomeWeb Daily News
RXi Q1 Loss Rises on Opko Deal Charge
May 16, 2013 / Gene Silencing News